Redhawk Wealth Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-14,230
Closed -$686K – 282
2021
Q1
$686K Buy
14,230
+1,157
+9% +$60.2K 0.17% 114
2020
Q4
$704K Buy
13,073
+2,361
+22% +$107K 0.18% 98
2020
Q3
$395K Buy
+10,712
New +$398K 0.11% 143

Other funds holding NEO

Redhawk Wealth Advisors's NEO Position: Q2 2021 in Review

Redhawk Wealth Advisors sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 14,230 shares — an estimated $686K sold.

Redhawk Wealth Advisors first reported a position in NEO in Q3 2020 and held it in 3 quarters. The position peaked at $704K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

  • Redhawk Wealth Advisors reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 14,230 NeoGenomics shares in Q2 2021, an estimated $686K.
  • Redhawk Wealth Advisors first reported a position in NeoGenomics in Q3 2020 and held it in 3 quarters.
  • Redhawk Wealth Advisors's NeoGenomics position peaked at $704K in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2021, filed 4 Aug 2021.